Gerald L. Ray & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $1.55M | Buy |
17,845
+625
| +4% | +$54.1K | 0.19% | 116 |
|
|
2017
Q2 | $1.33M | Buy |
17,220
+850
| +5% | +$65.6K | 0.17% | 122 |
|
|
2017
Q1 | $1.14M | Buy |
16,370
+1,635
| +11% | +$113K | 0.16% | 128 |
|
|
2016
Q4 | $872K | Buy |
14,735
+1,035
| +8% | +$61.3K | 0.13% | 149 |
|
|
2016
Q3 | $908K | Sell |
13,700
-500
| -4% | -$33.1K | 0.14% | 142 |
|
|
2016
Q2 | $768K | Buy |
14,200
+2,275
| +19% | +$123K | 0.12% | 151 |
|
|
2016
Q1 | $616K | Buy |
11,925
+375
| +3% | +$19.4K | 0.1% | 170 |
|
|
2015
Q4 | $811K | Buy |
11,550
+450
| +4% | +$31.6K | 0.13% | 138 |
|
|
2015
Q3 | $691K | Buy |
11,100
+150
| +1% | +$9.34K | 0.12% | 156 |
|
|
2015
Q2 | $921K | Sell |
10,950
-180
| -2% | -$15.1K | 0.14% | 140 |
|
|
2015
Q1 | $837K | Hold |
11,130
| – | – | 0.13% | 149 |
|
|
2014
Q4 | $692K | Buy |
11,130
+900
| +9% | +$56K | 0.11% | 167 |
|
|
2014
Q3 | $532K | Buy |
10,230
+300
| +3% | +$15.6K | 0.09% | 189 |
|
|
2014
Q2 | $510K | Buy |
9,930
+2,550
| +35% | +$131K | 0.09% | 191 |
|
|
2014
Q1 | $351K | Buy |
7,380
+780
| +12% | +$37.1K | 0.06% | 226 |
|
|
2013
Q4 | $286K | Buy |
6,600
+1,275
| +24% | +$55.3K | 0.05% | 239 |
|
|
2013
Q3 | $229K | Buy |
+5,325
| New | +$229K | 0.05% | 244 |
|